OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
002467 NET263 Ltd.
- 5.63
- 0.000.00%
Not Open Apr 1 15:00 CST
7.74BMarket Cap112.60P/E (TTM)
5.72High5.62Low289.54KlotVolume5.67Open5.63Pre Close164.29MTurnover2.12%Turnover Ratio112.60P/E (Static)1.38BShares9.5952wk High4.08P/B7.68BFloat Cap3.0752wk Low6.19Limit Up1.36BShs Float18.55Historical High5.07Limit Down1.78%Amplitude0.94Historical Low--Dividend TTM5.67Avg Price144.35KlotAsk--Div YieldTTM100Lot Size141.89KlotBid
NET263 Ltd. Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 0.76%944.34M | 2.48%709.46M | 7.83%481.53M | 14.76%257.93M | -0.54%937.22M | -5.20%692.27M | -0.74%446.55M | 3.17%224.76M | 4.37%942.35M | 11.61%730.25M |
| Refunds of taxes and levies | -22.05%671.5K | 102.07%510.5K | 59.51%362.1K | 62.25%186.96K | -73.24%861.49K | -92.10%252.63K | -92.91%227.01K | 14.58%115.23K | 612.67%3.22M | 663.90%3.2M |
| Cash received relating to other operating activities | 57.37%25.92M | 32.08%17.06M | -33.41%6.74M | -43.81%4.34M | 6.53%16.47M | -16.36%12.92M | -10.41%10.12M | 28.73%7.72M | -43.62%15.46M | 14.49%15.44M |
| Cash inflows from operating activities | 1.72%970.93M | 3.06%727.03M | 6.94%488.63M | 12.84%262.46M | -0.67%954.55M | -5.80%705.44M | -1.62%456.9M | 3.86%232.6M | 3.25%961.03M | 12.07%748.89M |
| Goods services cash paid | 2.73%481.46M | 7.94%363.09M | 9.13%241.35M | 12.35%125.62M | 7.09%468.65M | -3.33%336.37M | -0.11%221.16M | -0.11%111.81M | 10.14%437.6M | 21.99%347.96M |
| Staff behalf paid | -8.41%236.92M | -9.97%178.16M | -12.16%124.13M | -16.37%65.79M | -12.63%258.67M | -10.76%197.9M | -7.39%141.33M | -7.70%78.67M | -0.14%296.06M | -1.95%221.75M |
| All taxes paid | 39.40%22.2M | 70.98%14.94M | 177.01%10.23M | 107.23%4.8M | -62.19%15.93M | -77.58%8.74M | -87.09%3.69M | -73.45%2.31M | 40.34%42.13M | 82.93%38.96M |
| Cash paid relating to other operating activities | -2.70%69.57M | -1.12%53.87M | -5.61%36.42M | 23.58%24.41M | -2.22%71.5M | -4.65%54.48M | 6.07%38.59M | -15.13%19.75M | -7.66%73.12M | -19.48%57.13M |
| Cash outflows from operating activities | -0.56%810.15M | 2.10%610.06M | 1.82%412.14M | 3.80%220.62M | -4.02%814.75M | -10.26%597.48M | -7.79%404.77M | -7.25%212.55M | 5.72%848.92M | 10.30%665.81M |
| Net cash flows from operating activities | 15.00%160.78M | 8.35%116.97M | 46.73%76.49M | 108.67%41.84M | 24.70%139.8M | 29.95%107.96M | 105.13%52.13M | 485.74%20.05M | -12.27%112.11M | 28.69%83.08M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -99.32%28.1M | -99.78%9M | ---- | ---- | 1,303.37%4.11B | 2,541.41%4.11B | 2,206.48%3.46B | 794.80%1.34B | 53.73%292.53M | 15.67%155.42M |
| Cash received from returns on investments | -66.48%7.27M | -66.64%6.11M | -70.20%3.72M | -69.64%2.21M | 23.50%21.68M | 22.39%18.32M | 32.92%12.47M | 158.53%7.28M | 96.89%17.56M | 32.31%14.97M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 7,367.42%10.55M | 8,666.46%10.54M | 29,151.31%10.53M | 68,127.81%10.51M | 44.86%141.31K | 45.86%120.2K | -48.06%36.01K | 11.75%15.41K | -87.65%97.55K | -37.28%82.41K |
| Cash received relating to other investing activities | -30.15%1.3B | -25.40%1.06B | -43.03%650M | -33.46%350M | -14.31%1.86B | -24.09%1.42B | -17.16%1.14B | 34.87%526M | 41.08%2.17B | 103.15%1.87B |
| Cash inflows from investing activities | -77.52%1.35B | -80.42%1.09B | -85.61%664.25M | -80.67%362.73M | 141.26%5.99B | 171.49%5.54B | 200.34%4.62B | 245.63%1.88B | 42.37%2.48B | 90.66%2.04B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 111.56%67.69M | -12.87%23.37M | -7.98%16.45M | 70.07%11.04M | -41.79%32M | -24.10%26.83M | -15.12%17.88M | -36.28%6.49M | -0.78%54.97M | -19.33%35.34M |
| Cash paid to acquire investments | -99.90%4M | -99.90%4M | -99.91%3M | -99.78%3M | 2,208.13%4.05B | 12,115.85%4.03B | 11,535.35%3.49B | 4,474.72%1.37B | 82.40%175.52M | -48.68%33M |
| Cash paid relating to other investing activities | -31.76%1.16B | -32.06%890M | -36.52%565M | -15.73%337.1M | -30.69%1.7B | -35.21%1.31B | -40.13%890M | -23.08%400M | 48.74%2.45B | 132.09%2.02B |
| Cash outflows from investing activities | -78.70%1.23B | -82.91%917.37M | -86.71%584.45M | -80.26%351.14M | 115.52%5.78B | 156.82%5.37B | 186.08%4.4B | 217.55%1.78B | 47.73%2.68B | 113.45%2.09B |
| Net cash flows from investing activities | -44.24%114.22M | -4.73%168.27M | -63.35%79.8M | -88.14%11.59M | 201.73%204.83M | 468.53%176.62M | 41,988.20%217.73M | 667.28%97.74M | -175.54%-201.36M | -152.16%-47.93M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | -84.17%5.54M | --5.92M | --5.92M | ---- | 114.39%34.98M | ---- |
| Cash received relating to other financing activities | -98.88%14.4K | -98.88%14.4K | --14.4K | --14.4K | --1.29M | --1.29M | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | -99.79%14.4K | -99.80%14.4K | -99.76%14.4K | --14.4K | -80.48%6.83M | --7.21M | --5.92M | ---- | 114.39%34.98M | ---- |
| Borrowing repayment | --0 | --0 | ---- | ---- | --212.04K | ---- | ---- | ---- | ---- | ---- |
| Dividend interest payment | ---- | ---- | ---- | ---- | --221.68M | --221.68M | --221.68M | ---- | ---- | ---- |
| Cash payments relating to other financing activities | 343.06%61.34M | 427.14%57.11M | 4.92%8.94M | -23.22%3.26M | -3.05%13.85M | 2.13%10.83M | 18.40%8.52M | 6.49%4.25M | -6.05%14.28M | -5.42%10.61M |
| Cash outflows from financing activities | -73.98%61.34M | -75.44%57.11M | -96.12%8.94M | -23.22%3.26M | 1,550.65%235.74M | 2,091.78%232.52M | 3,098.32%230.2M | 6.49%4.25M | -93.52%14.28M | -95.09%10.61M |
| Net cash flows from financing activities | 73.21%-61.33M | 74.66%-57.1M | 96.02%-8.93M | 23.56%-3.25M | -1,205.78%-228.91M | -2,023.81%-225.31M | -3,016.06%-224.28M | -6.49%-4.25M | 110.15%20.7M | 94.76%-10.61M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 1.18%1.13M | -471.70%-6.11M | -76.00%495.99K | 91.88%-75.33K | -81.33%1.11M | -75.73%1.64M | -29.63%2.07M | -50.34%-928.21K | 265.60%5.97M | 556.19%6.77M |
| Net increase in cash and cash equivalents | 83.84%214.8M | 264.48%222.04M | 210.36%147.86M | -55.51%50.11M | 286.69%116.84M | 94.50%60.92M | 130.90%47.64M | 516.59%112.62M | 59.05%-62.58M | 166.01%31.32M |
| Add:Begin period cash and cash equivalents | 47.79%361.33M | 47.79%361.33M | 47.79%361.33M | 47.79%361.33M | -20.38%244.49M | -20.38%244.49M | -20.38%244.49M | -20.38%244.49M | -33.23%307.07M | -33.23%307.07M |
| End period cash equivalent | 59.45%576.12M | 91.01%583.36M | 74.30%509.19M | 15.21%411.44M | 47.79%361.33M | -9.75%305.41M | -10.86%292.13M | 27.52%357.11M | -20.38%244.49M | -17.95%338.39M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.